HCPCS Level II J1836: Metronidazole Injection, 10 mg
HCPCS Level II code J1836 represents an injectable formulation of metronidazole, 10 mg, used for parenteral antimicrobial therapy; the service is drug administration typically delivered in inpatient hospital or outpatient infusion/clinic settings where intravenous or intramuscular medications are given.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J1836 policy alerts
Get alerted when payer policies referencing J1836 are released or updated.
Monitor payer policy activity